Stocks Comparison
BioCorRx vs Elite Health Systems: revenue, profit, margins and growth compared
BioCorRx brought in $797.2K of revenue in fiscal 2025, Elite Health Systems $1M in fiscal 2025. BioCorRx kept -431.5% of its revenue as net profit, Elite Health Systems -762.1%.
Side by side, latest fiscal year
| BICX | EHSI | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $797.2K | $1M |
| Revenue growth | +10,301.1% | n/a |
| Net income | -$3.4M | -$7.8M |
| Net margin | -431.5% | -762.1% |
| Free cash flow | n/a | -$2.9M |
| Free cash flow margin | n/a | -287.8% |
| Earnings per share (diluted) | -$0.19 | -$0.35 |
| Cash | $139.4K | $3.8M |
| Debt | n/a | n/a |
| Price to earnings | n/a | n/a |
| Market value | $6M | $24.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #655 of 742 · Health care | #641 of 742 · Health care |
Over the years
BICX $797.2KEHSI $1M
BICX -$3.4MEHSI -$7.8M
BICX -431.5%EHSI -762.1%
BICX +10,301.1%EHSI -100.0%
BICX -$2MEHSI -$2.9M
Questions about BioCorRx and Elite Health Systems
Which is bigger by revenue, BioCorRx or Elite Health Systems?
Elite Health Systems is bigger by revenue: $1M in fiscal 2025, against $797.2K for BioCorRx in fiscal 2025.
Which keeps more of its revenue as profit, BioCorRx or Elite Health Systems?
BioCorRx had a net margin of -431.5% in fiscal 2025; Elite Health Systems had -762.1% in fiscal 2025.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.